Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Velosa, Ana P P ^a   Teodoro, Walcy R ^a   dos Anjos, Daniel M ^a   Konno, Renata ^a   Oliveira, Cristiane C ^a   Katayama, Maria L H ^a   Parra, Edwin R ^a   Capelozzi, Vera L ^a   Yoshinari, Natalino H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 5; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LUNG INTERSTITIUM; LUNG PARENCHYMA; MORPHOMETRICS; NEW ZEALAND; NONHUMAN; PROTEIN EXPRESSION; RABBIT; SYSTEMIC SCLEROSIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; HUMAN; INTRANASAL DRUG ADMINISTRATION; LUNG; METABOLISM;

ADMINISTRATION, INTRANASAL; ANIMALS; COLLAGEN TYPE V; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; LUNG; RABBITS; RNA, MESSENGER; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 77952523414     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-1     Document Type: Article

References (37)

1. Dorfmüller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, Capron F. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007, 38(6):893-902.
2. Lakos G, Takagawa S, Varga J. Animal models of scleroderma. Methods Mol Med 2004, 102:377-93.
3. Nguyen VA, Sgonc R, Dietrich H, Wick G. Endothelial injury in internal organs of University of California at Davis line 200 (UCD 200) chickens, an animal model for systemic sclerosis (Scleroderma). J Autoimmun 2000, 14(2):143-149.
4. Niyibizi C, Fietzek, Rest M. Human placenta Collagen Vs. Evidence for existence of a α1(V), α2(V), α3(V). Col Mol 1984, 259:14170-4.
5. Imamura Y, Scott IC, Greenspan DS. The pro-alpha 3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J Biol Chem 2000, 275(12):8749-59.
6. Madri JA, Furthmayr H. Collagen Polymorphism in the Lung-An Immunochemical Study of Pulmonary Fibrosis. Human Pathology 1980, 11(4):353-66.
7. Wilkes DS. Autoimmune responses to grafted lungs: immune responses to a native collagen-Collagen V. Graft 2003, 6(1):42-9.
8. Wilkes DS. The role of autoimmunity in the pathogenesis of lung allograft rejection. Arch Immunol Ther Exp (Warsz) 2003, 51(4):227-230.
9. Unsöld C, Pappano WN, Imamura Y, Steiglitz BM, Greenspan DS. Biosynthetic processing of the pro-1 (V)2 pro-2(V) collagen heterotrimer by bone morphogenetic protein-1 and furin-like proprotein convertases. J Biol Chem 2002, 277(7):5596-602.
10. Sato K, Tanahashi-Siina T, Jun F, Watanabe-Kawamura A, Ichinomiya M, Minegishi Y, Tsukamasa Y, Nakamura Y, Kawabata M, Ohtsuki K. Simple and rapid chromatographic purification of Collagen V from a pepsin digest of porcine instestinal connective tissue, an unmanageable starting material for convenctional column chromatography. J Chromatogr 2003, 790:277-83.
11. Teodoro WR, Velosa AP, Witzel SS, Garippo AL, Farhat C, Parra ER, Sonohara S, Capelozzi VL, Yoshinari NH. Architectural remodelling in lungs of rabbits induced by Collagen V immunization: a preliminary morphologic model to study diffuse connective tissue diseases. Pathol Res Pract 2004, 200(10):681-691.
12. Bezerra MC, Teodoro WR, de Oliveira CC, Velosa AP, Ogido LT, Gauditano G, Parra ER, Capelozzi VL, Yoshinari NH. Scleroderma-like remodeling induced by Collagen V. Arch Dermatol Res 2006, 298(2):51-57.
13. Yoshinari NH, Teodoro WR, Ogido LTI, Velosa APP, Prizon CP, Miron B, Bissoli JCC, Cuentas ERP, Capelozzi VL. Modelo experimental de doenças difusas do tecido conjuntivo (DDTC) induzido por colágeno do tipo V. Rev Bras Reumatol 2002, 42:295-305.
14. Teodoro WR, Miron BG, Tsuzuki L, Ogido I, Velosa AP, Abatepaulo F, Capelozzi VL, Yoshinari NH. Synovial remodeling process induced by Collagen V immunization in rabbits. Pathol Res Pract 2003, 199(9):605-612.
15. Callado MR, Viana VS, Vendramini MB, Leon EP, Bueno C, Velosa AP, Teodoro WR, Yoshinari NH. Autoantibody profile in the experimental model of scleroderma induced by type V human collagen. Immunology 2007, 122(1):38-46. 2265984, 17442023.
16. Sakkas LI, Xu B, Artlett CM, Lu S, Jimenez S, A Platsoucas CD. Oligoclonal T Cell Expansion in the Skin of Patients with Systemic Sclerosis. J Immunol 2002, 168:3649-3659.
17. Sakkas LI, Platsoucas CD. Is systemic sclerosis an antigen-driven T cell disease?. Arthritis Rheum 2004, 50(6):1721-1733.
18. Velosa AP, Teodoro WR, de Oliveira CC, dos Santos Filho A, Moutinho RF, Santos AG, Vendramini MB, Bueno C, Parra ER, Capelozzi VL, Yoshinari NH. Collagen V nasal tolerance in experimental model of systemic sclerosis. Arch Dermatol Res 2007, 299(4):177-189.
19. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96(10):857-881.
20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
21. Parra ER, Kairalla RA, Ribeiro de Carvalho CR, Eher E, Capelozzi VL. Inflammatory cell phenotyping of the pulmonary interstitium in idiopathic interstitial pneumonia. Respiration 2007, 74:159-69.
22. Mestecky J, Moldoveanu Z, Elson CO. Immune response versus mucosal tolerance to mucosally administered antigens. Vaccine 2005, 23(15):1800-1803.
23. Faria AMC, Weiner HL. Oral tolerance: mechanisms and therapeutic application. Adv Immunol 1999, 73:153-265.
24. Weiner HL. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-β-secreting regulatory cells. Microbes Infect 2001, 3(11):947-954.
25. Faria AMC, Weiner HL. Oral tolerance. Immunol Rev 2005, 206:232-259.
26. Faria AM, Weiner HL. Oral tolerance: Therapeutic implications for autoimmune diseases. Clin Dev Immunol 2006, 13(2):143-157. 2270752, 17162357.
27. Jonuleit H, Schmitt E. The Regulatory T cell family: Distinct subsets and their interrelations. J Immunol 2003, 17(12):6323-6327.
28. Ihn H. Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 2008, 49(2):103-113.
29. Mares DC, Heidler KM, Smith GN, Cummings OW, Harris ER, Foreman BH, Cummings OW, Harris ER, Foresman B, Wilkes DS. Collagen V modulates alloantigen-induced pathology and immunology in the lung. Am J Respir Cell Mol Biol 2000, 23:62-70.
30. Haque MA, Myzobuchi T, Yasufuku K, Fujisawa T, Brutkiewicz RR, Zheng Y, Woods K, Smith GN, Cummings OW, Heidler KM, Blum JS, Wilkes DS. Evidence for immune responses to a self antigen in lung transplantation: role of Collagen V-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002, 69:1542-1549.
31. Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to Collagen V in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol 2004, 286(6):L1129-L1139.
32. Yoshida S, Haque A, Mizobuchi T, Iwata T, Chiyo M, Webb TJ, Baldridge LA, Heidler KM, Cummings OW, Fujisawa T, Blum JS, Brand DD, Wilkes DS. Anti-Collagen V lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006, 6(4):724-735.
33. Yasufuku K, Heidler KM, O'Donell PW, Smith GN, Cummings OW, Foresman BH, Fujisawa T, Wilkes DS. Oral tolerance induction by Collagen V Downregulates lung allograft. Am J Respir Cell Mol Biol 2001, 25(1):26-34.
34. Garippo AL, Parra ER, Teodoro WR, Veloza AP, Yoshinari NH, Capelozzi VL. Immune cell infiltration and broncovascular remodeling after nitric acid nasal instillation in a mouse bronchiolitis obliterans model. Lung 2006, 184(4):229-38.
35. Mizobuchi T, Yasufuku K, Zheng Y, Haque MA, Heidler KM, Woods K, Smith GN, Cummings OW, Fujisawa T, Blum JS, Wilkes DS. Differential expression of Smad7 transcripts identifies the CD4+CD45RChigh regulatory T cells that mediate Collagen V-induced tolerance to lung allografts. J Immunol 2003, 171(3):1140-1147.
36. Mckown KM, Carbone LD, Bustillo J, Seyer JM, Kang AH, Postlethwaite AE. Induction of immune tolerance to human type I collagen in patients with systemic sclerosis by oral administration of bovine type I collagen. Arthitis Rheum 2000, 43(5):1054-1061.
37. Postlethwaite AE, Wong WK, Clements P, Chatterjee S, Fessler BJ, Kang AH, Korn J, Mayes M, Merkel PA, Molitor JA, Moreland L, Rothfield N, Simms RW, Smith EA, Spiera R, Steen V, Warrington K, White B, Wigley F, Furst DE. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease. Arthritis Rheum 2008, 58(6):1810-1822.